Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023

The global esoteric testing market was valued at USD 18.46 Billion in 2017 and is projected to reach USD 35.24 Billion by 2023, at a CAGR of 11.6% during the forecast period. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.

Objectives of the study are:

• To define, describe, and forecast the global market by type, technology, and laboratory type
• To provide detailed information regarding major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and industry trends)
• To analyze various segments covered in the study with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To strategically profile key players in this market and comprehensively analyze their market shares and core competencies
• To forecast the market size of the global market with respect to the five key regions (along with countries), namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
• To track and analyze competitive developments such as joint ventures, agreements, and partnerships; mergers and acquisitions; product launches; and research and development activities in the global market

Research Methodology

The study estimates the esoteric testing market size for 2018 and projects its demand till 2023. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the supply side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the global market. Primary sources from the demand side include physicians, nurses, pathologists, and laboratory technicians. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the esoteric testing market. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. This research study involves the extensive usage of secondary sources, directories, and databases, in order to identify and collect information useful for this technical, market-oriented, and financial study of the global market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

To know about the assumptions considered for the study, download the pdf brochure

In 2017, LabCorp (US), Quest Diagnostics (US), and OPKO Health (US) held the leading positions in the global esoteric testing market. Myriad Genetics (US), Genomic Health (US), American Medical Laboratories (US), Foundation Medicine (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (Australia), Fulgent Genetics (US), InVitae (US), Spectra Laboratories (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Enzo Biochem (US), Clinical Reference Laboratory (US), Sequenom (US), and American Pathology Partners (US) are the other major players operating in this market.

Target Audience for this Report:

• Independent/reference laboratories
• Clinical laboratory testing service providers
• Diagnostic companies
• Suppliers and distributors of diagnostic test kits
• OEM manufacturers
• Healthcare service providers (including hospital-affiliated laboratories)
• Medical institutes
• Health insurance players
• Pharmaceutical, biopharmaceutical, and biotechnology companies
• Market research and consulting firms

Scope of the Report

This report categorizes the global market into the following segments:

Global Esoteric Testing Market, by Type

• Infectious Diseases Testing
• Endocrinology Testing
• Oncology testing
• Immunology Testing
• Genetic Testing
• Toxicology Testing
• Neurology Testing
• Others

Global Esoteric Testing Market, by Technology

• Chemiluminescence Immunoassay (CLIA)
• Enzyme-linked Immunosorbent Assay (ELISA)
• Mass Spectrometry
• Real Time - PCR
• Flow Cytometry
• Radioimmunoassay
• Others

Global Esoteric Testing Market, by Laboratory Type

• Independent & Reference Laboratories
• Hospital Laboratories

Global Esoteric Testing Market, by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • RoE
• Asia Pacific
  • Japan
  • China
  • India
  • RoAPAC
• Latin America
  • Brazil
  • Mexico
  • RoLA
• Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

• Product matrix, which gives a detailed comparison of the service portfolio of each company

Geographic Analysis

• Further breakdown of the Rest of Asia Pacific esoteric testing market in Russia, South Korea, Taiwan, Australia, New Zealand, and other countries

Company Information

• Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Regional Scope
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primaries
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Data Triangulation
    2.4 Assumptions

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 33)
    4.1 Attractive Market Opportunities in the Esoteric Testing Market
    4.2 Asia Pacific: Market, By Type
    4.3 Global Market: Regional Growth Opportunities
    4.4 Global Market: Regional Mix
    4.5 Global Market: Developed vs Developing Countries

5 Market Overview (Page No. - 38)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Geriatric Population and Subsequent Growth in the Prevalence of Chronic Diseases
                    5.2.1.2 Increasing Burden of Infectious Diseases
                    5.2.1.3 Rising Demand for Early Disease Detection Using Specialized Diagnostic Tests
                    5.2.1.4 Growing Awareness of Personalized Medicine
                    5.2.1.5 Increasing Funding and Research Grants for the Development of Innovative Esoteric Tests
           5.2.2 Restraints
                    5.2.2.1 Unfavorable Reimbursement Scenario
           5.2.3 Opportunities
                    5.2.3.1 Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
                    5.2.3.2 Growth Opportunities in Emerging Countries
           5.2.4 Challenges
                    5.2.4.1 Changing Regulatory Landscape

6 Industry Insights (Page No. - 46)
    6.1 Introduction
    6.2 Industry Trends
    6.3 Regulatory Analysis
           6.3.1 North America
                    6.3.1.1 US
                    6.3.1.2 Canada
           6.3.2 Europe
           6.3.3 Asia-Pacific
                    6.3.3.1 Japan
                    6.3.3.2 India
                    6.3.3.3 China

7 Esoteric Testing Market, By Type (Page No. - 51)
    7.1 Introduction
    7.2 Infectious Diseases Testing
    7.3 Endocrinology Testing
    7.4 Oncology Testing
    7.5 Genetic Testing
    7.6 Toxicology Testing
    7.7 Immunology Testing
    7.8 Neurology Testing
    7.9 Others

8 Esoteric Testing Market, By Technology (Page No. - 76)
    8.1 Introduction
    8.2 Chemiluminescence Immunoassay
    8.3 Enzyme-Linked Immunosorbent Assay
    8.4 Mass Spectrometry
    8.5 Real-Time PCR
    8.6 Flow Cytometry
    8.7 Radioimmunoassay
    8.8 Other Technologies

9 Global Esoteric Testing Market, By Laboratory Type (Page No. - 86)
    9.1 Introduction
    9.2 Independent & Reference Laboratories
    9.3 Hospital Laboratories

10 Esoteric Testing Market, By Region (Page No. - 91)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 UK
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe
     10.4 Asia Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Latin America
             10.5.1 Brazil
             10.5.2 Mexico
             10.5.3 Rest of Latin America
     10.6 Middle East & Africa

11 Competitive Landscape (Page No. - 142)
     11.1 Overview
     11.2 Market Share Analysis, 2016
     11.3 Competitive Scenario
             11.3.1 Product Launches
             11.3.2 Agreements, Partnerships, and Collaborations
             11.3.3 Mergers and Acquisitions
             11.3.4 Expansions

12 Company Profiles (Page No. - 148)
(Business Overview, Products Offered, Recent Developments, SWOT Anlysis, MnM View.)*
     12.1 Labcorp
     12.2 Quest Diagnostics
     12.3 Opko Health
     12.4 Miraca Holdings
     12.5 Myriad Genetics
     12.6 Sonic Healthcare
     12.7 Primary Health Care
     12.8 Healthscope
     12.9 Foundation Medicine
     12.10 ACM Global Laboratories
     12.11 Arup Laboratories
     12.12 Fulgent Genetics
     12.13 Invitae
     12.14 Mayo Medical Laboratories
     12.15 Spectra Laboratories

*Business Overview, Products Offered, Recent Developments, SWOT Anlysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 212)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details

List of Tables (110 Tables)

Table 1 New Tests Launches By Key Players
Table 2 Esoteric Testing Market: Recent Acquisitions
Table 3 Global Market: Recent Collaborations and Agreements
Table 4 Stringency of Regulations for Clinical Laboratory Accreditation, By Country
Table 5 Accreditation Bodies in Europe
Table 6 Global Market, By Type, 2016–2023 (USD Million)
Table 7 Esoteric Tests for Infectious Diseases, By Key Market Player
Table 8 Infectious Diseases Esoteric Testing Market, By Country/Region, 2016–2023 (USD Million)
Table 9 Esoteric Tests for Endocrine Diseases, By Key Market Player
Table 10 Endocrinology Esoteric Testing Market, By Country/Region, 2016–2023 (USD Million)
Table 11 Esoteric Tests for Oncological Diseases, By Key Market Player
Table 12 Oncology Esoteric Testing Market, By Country/Region, 2016–2023 (USD Million)
Table 13 Esoteric Tests for Genetic Disorders, By Key Market Player
Table 14 Genetics Esoteric Testing Market, By Country/Region, 2016–2023 (USD Million)
Table 15 Esoteric Tests for Toxicology, By Key Market Player
Table 16 Toxicology Esoteric Testing Market, By Country/Region, 2016–2023 (USD Million)
Table 17 Esoteric Tests for Immunological Diseases, By Key Market Player
Table 18 Immunology Esoteric Testing Market, By Country/Region, 2016–2023 (USD Million)
Table 19 Esoteric Tests for Neurological Disorders, By Key Market Player
Table 20 Neurology Esoteric Testing Market, By Country/Region, 2016–2023 (USD Million)
Table 21 Other Esoteric Testing Market, By Country/Region, 2016–2023 (USD Million)
Table 22 Global Market, By Technology, 2016–2023 (USD Million)
Table 23 Chemiluminescence Immunoassay Market for Esoteric Testing, By Country/Region, 2016–2023 (USD Million)
Table 24 Enzyme-Linked Immunosorbent Assay Market for Esoteric Testing, By Country/Region, 2016–2023 (USD Million)
Table 25 Mass Spectrometry Market for Esoteric Testing, By Country/Region, 2016–2023 (USD Million)
Table 26 Real-Time PCR Market for Esoteric Testing, By Country/Region, 2016–2023 (USD Million)
Table 27 Flow Cytometry Market for Esoteric Testing, By Country/Region, 2016–2023 (USD Million)
Table 28 Radioimmunoassay Market for Esoteric Testing, By Country/Region, 2016–2023 (USD Million)
Table 29 Other Esoteric Technologies Market, By Country/Region, 2016–2023 (USD Million)
Table 30 Global Market, By Laboratory Type, 2016–2023 (USD Million)
Table 31 Global Market for Independent & Reference Laboratories, By Country/Region, 2016–2023 (USD Million)
Table 32 Global Market for Hospital Laboratories, By Country/Region, 2016–2023 (USD Million)
Table 33 Global Market, By Region, 2016–2023 (USD Million)
Table 34 North America: Esoteric Testing Market, By Country, 2016–2023 (USD Million)
Table 35 North America: Market, By Type, 2016–2023 (USD Million)
Table 36 North America: Market, By Technology, 2016–2023 (USD Million)
Table 37 North America: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 38 U.S.: Infectious Disease Incidence, 2008-2012
Table 39 US: Key Macroindicators
Table 40 US: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 41 US: Market, By Technology, 2016–2023 (USD Million)
Table 42 US: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 43 Canada: Key Macroindicators
Table 44 Canada: Market, By Type, 2016–2023 (USD Million)
Table 45 Canada: Esoteric Testing Market, By Technology, 2016–2023 (USD Million)
Table 46 Canada: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 47 Europe: Market, By Country/Region, 2016–2023 (USD Million)
Table 48 Europe: Market, By Type, 2016–2023 (USD Million)
Table 49 Europe: Esoteric Testing Market, By Technology, 2016–2023 (USD Million)
Table 50 Europe: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 51 Germany: Key Macroindicators
Table 52 Germany: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 53 Germany: Market, By Technology, 2016–2023 (USD Million)
Table 54 Germany: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 55 France: Key Macroindicators
Table 56 France: Market, By Type, 2016–2023 (USD Million)
Table 57 France Esoteric Testing Market, By Technology, 2016–2023 (USD Million)
Table 58 France: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 59 UK: Key Macroindicators
Table 60 UK: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 61 UK: Market, By Technology, 2016–2023 (USD Million)
Table 62 UK: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 63 Italy: Key Macroindicators
Table 64 Italy: Market, By Type, 2016–2023 (USD Million)
Table 65 Italy: Esoteric Testing Market, By Technology, 2016–2023 (USD Million)
Table 66 Italy: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 67 Spain: Key Macroindicators
Table 68 Spain: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 69 Spain: Market, By Technology, 2016–2023 (USD Million)
Table 70 Spain: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 71 RoE: Market, By Type, 2016–2023 (USD Million)
Table 72 RoE: Esoteric Testing Market, By Technology, 2016–2023 (USD Million)
Table 73 RoE: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 74 Asia Pacific: Market, By Country/Region, 2016–2023 (USD Million)
Table 75 Asia Pacific: Market, By Type, 2016–2023 (USD Million)
Table 76 Asia Pacific: Esoteric Testing Market, By Technology, 2016–2023 (USD Million)
Table 77 Asia Pacific: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 78 Japan: Key Macroindicators
Table 79 Japan: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 80 Japan: Market, By Technology, 2016–2023 (USD Million)
Table 81 Japan: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 82 China: Key Macroindicators
Table 83 China: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 84 China: Market, By Technology, 2016–2023 (USD Million)
Table 85 China: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 86 India: Key Macroindicators
Table 87 India: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 88 India: Market, By Technology, 2016–2023 (USD Million)
Table 89 India: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 90 RoAPAC: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 91 RoAPAC: Market, By Technology, 2016–2023 (USD Million)
Table 92 RoAPAC: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 93 Rest of Latin America: Market, By Country/Region, 2016–2023 (USD Million)
Table 94 Latin America: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 95 Latin America: Market, By Technology, 2016–2023 (USD Million)
Table 96 Latin America: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 97 Brazil: Key Macroindicators
Table 98 Brazil: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 99 Brazil: Market, By Technology, 2016–2023 (USD Million)
Table 100 Brazil: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 101 Mexico: Key Macroindicators
Table 102 Mexico: Esoteric Testing Market, By Type, 2016–2023 (USD Million)
Table 103 Mexico: Market, By Technology, 2016–2023 (USD Million)
Table 104 Mexico: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 105 Rest of Latin America: Market, By Type, 2016–2023 (USD Million)
Table 106 Rest of Latin America: Esoteric Testing Market, By Technology, 2016–2023 (USD Million)
Table 107 Rest of Latin America: Market, By Laboratory Type, 2016–2023 (USD Million)
Table 108 Middle East & Africa: Market, By Type, 2016–2023 (USD Million)
Table 109 Middle East & Africa: Market, By Technology, 2016–2023 (USD Million)
Table 110 Middle East & Africa: Esoteric Testing Market, By Laboratory Type, 2016–2023 (USD Million)

List of Figures (37 Figures)

Figure 1 Research Design
Figure 2 Data Triangulation Methodology
Figure 3 Infectious Disease Testing Segment to Dominate the Global Esoteric Testing Market, By Type, in 2018
Figure 4 Real-Time PCR Segment to Register the Highest Growth Rate in the global Market During the Forecast Period
Figure 5 Independent & Reference Laboratories to Be the Fastest-Growing Segment in the Market Between 2018 & 2023
Figure 6 Asia Pacific to Witness the Highest Growth Rate in the Forecast Period
Figure 7 Increasing Prevalence of Chronic & Infectious Diseases–Key Factor Driving the Growth of the Market
Figure 8 Genetic Testing Segment to Register the Highest Growth Rate in the APAC Esoteric Testing Market During the Forecast Period
Figure 9 Emerging Countries to Register Highest CAGR During the Forecast Period
Figure 10 North America to Dominate the Esoteric Testing Market in the Forecast Period
Figure 11 Developing Countries to Register A Higher Growth Rate in the Forecast Period
Figure 12 Esoteric Testing Market: Drivers, Restraints, Opportunities, & Challenges
Figure 13 Increase in Geriatric Population, By Country 2011 vs 2015 vs 2030
Figure 14 Major Trend: Acquisitions Resulting in Market Consolidation
Figure 15 Esoteric Testing Market, By Type, 2018 vs 2023
Figure 16 Chemiluminescence Immunoassay Segment to Dominate the Esoteric Testing Market During the Forecast Period
Figure 17 Esoteric Testing Market, By Laboratory Type, 2018 vs 2023
Figure 18 Healthcare Expenditure Across Major Countries, 2000–2014
Figure 19 North America to Dominate the Market in 2023
Figure 20 Geographic Snapshot of the Global Market
Figure 21 North America: Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Asia Pacific: Market Snapshot
Figure 24 Players Majorly Adopted the Strategy of Product Launches Between January 2014 and March 2017
Figure 25 Global Esoteric Testing Market Share Analysis, By Key Player, 2016
Figure 26 Labcorp: Company Snapshot
Figure 27 Quest Diagnostics: Company Snapshot
Figure 28 Opko Health: Company Snapshot
Figure 29 Miraca Holdings: Company Snapshot
Figure 30 Myriad Genetics: Company Snapshot
Figure 31 Sonic Healthcare: Company Snapshot
Figure 32 Primary Health Care: Company Snapshot
Figure 33 Healthscope: Company Snapshot
Figure 34 Foundation Medicine: Company Snapshot
Figure 35 Fulgent Genetics: Company Snapshot
Figure 36 Mayo Medical Laboratories: Company Snapshot
Figure 37 Fresenius Medical Care: Company Snapshot

The global esoteric testing market is projected to reach USD 35.24 Billion by 2023 from USD 20.38 Billion in 2018, at a CAGR of 11.6%. The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, and advancements in clinical diagnostic techniques are the key factors driving the growth of the market.

This report broadly segments the esoteric testing market into type, technology, laboratory type, and region.

On the basis of type, the market is broadly divided into infectious diseases, immunology, endocrinology, oncology, genetics, toxicology, neurology, and others. The infectious diseases testing segment is expected to dominate the market in 2018. The large share of this segment is primarily attributed to the large volume of infectious disease tests being performed in clinical laboratories, growing global disease burden of chronic and infectious disorders, technological innovations in molecular diagnostics, and improving healthcare infrastructure in developing nations.

On the basis of laboratory type, the esoteric testing market is segmented into independent & reference laboratories and hospital laboratories. The independent & reference laboratories segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the ongoing automation and digitalization of diagnostic laboratories across major countries and significant reimbursement coverage for clinical tests performed at reference/independent laboratories in developed countries. The growing number of clinical tests being performed in laboratories, competitive benefits offered by these providers over hospital-based laboratories, and an increase in the number of accredited laboratories are also expected to support the growth of the esoteric testing market for independent & reference laboratories.

North America is expected to command the largest share of the market in 2018 owing to the government initiatives to promote awareness about preventive screening, growing public and private funding for research on the development of clinical laboratory tests, and increasing adoption of genome-based laboratory tests. However, Asia Pacific is expected to register the highest growth rate during the forecast period due to rising healthcare expenditure, increasing number of hospitals and clinical diagnostic laboratories in India and China, and strong research bases for esoteric testing procedures across India, China, and Japan.

The major factors driving the growth of this market in the North American region include accessibility to advanced technologies, the presence of a well-established network of independent & reference laboratories, expansion of molecular diagnostics for genetic disorders and cancer screening, and presence of major leading companies in the US.

The prominent players in the global esoteric testing market include LabCorp (US), OPKO Health (US), ARUP Laboratories (US), Miraca Holdings (Japan), Myriad Genetics (US), Genomic Health (US), Quest Diagnostics (US), American Medical Laboratories (US), Foundation Medicine (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (Australia), Fulgent Genetics (US), Invitae (US), Spectra Laboratories (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Enzo Biochem (US), Clinical Reference Laboratory (US), Sequenom (US), and American Pathology Partners (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst